Apria Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apria in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Apria stock.
View analyst ratings for Apria or view top-rated stocks.

Wall Street analysts have given Apria a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Apria wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Apria is scheduled to release its next quarterly earnings announcement on Tuesday, June 29th 2021.
View our earnings forecast for Apria.

Apria, Inc. (NYSE:APR) announced its quarterly earnings results on Tuesday, March, 30th. The company reported $26.06 earnings per share (EPS) for the quarter. The business earned $293.79 million during the quarter.
View Apria's earnings history.

Apria updated its first quarter 2021 After-Hours earnings guidance on Tuesday, March, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $268-272 million, compared to the consensus revenue estimate of $279.22 million.

5 brokerages have issued 1-year price objectives for Apria's stock. Their forecasts range from $26.00 to $33.00. On average, they expect Apria's stock price to reach $29.20 in the next twelve months. This suggests that the stock has a possible downside of 2.8%.
View analysts' price targets for Apria or view top-rated stocks among Wall Street analysts.

Some companies that are related to Apria include VIZIO (VZIO), SEMrush (SEMR), The Duckhorn Portfolio (NAPA), ThredUp (TDUP), Thoma Bravo Advantage (TBA), Design Therapeutics (DSGN), Bioventus (BVS), Ikena Oncology (IKNA), Churchill Capital Corp V (CCV), Adagene (ADAG), Custom Truck One Source (CTOS), Fifth Wall Acquisition Corp. I (FWAA), SVF Investment Corp. 3 (SVFC), Lava Therapeutics B.V. (LVTX) and United Time Technology (UTME).
View all of APR's competitors.

(APR) raised $150 million in an IPO on Thursday, February 11th 2021. The company issued 7,500,000 shares at a price of $19.00-$21.00 per share. Citigroup and Goldman Sachs & Co. LLC BofA Securities J.P. Morgan UBS Investment Bank served as the underwriters for the IPO and Piper Sandler Citizens Capital Markets Fifth Third Securities TD Securities Academy Securities Blaylock Van, LLC Penserra Securities LLC Stern was co-manager.

Apria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APR."

Apria's lock-up period expires on Tuesday, August 10th. Apria had issued 7,500,000 shares in its initial public offering on February 11th. The total size of the offering was $150,000,000 based on an initial share price of $20.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

Shares of APR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of APR stock can currently be purchased for approximately $30.05.

Apria has a market capitalization of $1.06 billion.

Apria employs 6,500 workers across the globe.

The official website for Apria is www.apria.com.

The company can be reached via phone at 800 990 9799.